Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 17/303% above fair value
$102.86+1.87 (+1.85%)
Close on Nov 13, 2026Market cap $131.57BP/E 25.3Yield 2.76%
Medtronic total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Medtronic's total debt was $28.15B at Jul 31, 2026. For fiscal 2026 it was $27.96B, down 1.9% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $36.19B in fiscal 2015.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $27.96B | -1.9% |
| FY2025 | Apr 25, 2025 | $28.52B | +14.0% |
| FY2024 | Apr 26, 2024 | $25.02B | +2.7% |
| FY2023 | Apr 28, 2023 | $24.36B | +1.0% |
| FY2022 | Apr 29, 2022 | $24.11B | -8.6% |
| FY2021 | Apr 30, 2021 | $26.39B | +6.4% |
| FY2020 | Apr 24, 2020 | $24.80B | -2.1% |
| FY2019 | Apr 26, 2019 | $25.32B | -1.7% |
| FY2018 | Apr 27, 2018 | $25.76B | -23.0% |
| FY2017 | Apr 28, 2017 | $33.44B | +7.5% |
| FY2016 | Apr 29, 2016 | $31.10B | -14.0% |
| FY2015 | Apr 24, 2015 | $36.19B | +203.4% |
| FY2014 | Apr 25, 2014 | $11.93B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $28.15B | -1.6% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $27.96B | -1.9% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $28.07B | +5.5% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $29.10B | +2.7% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $28.61B | +2.7% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $28.52B | +14.0% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $26.61B | +5.7% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $28.33B | +12.9% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $27.87B | +11.5% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $25.02B | +2.7% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $25.18B | -10.5% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $25.08B | -5.8% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $24.98B | +7.6% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $24.36B | +1.0% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $28.13B | +11.8% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $26.62B | +3.9% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $23.21B | -10.6% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $24.11B | -8.6% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $25.16B | -17.0% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $25.62B | -14.6% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $25.96B | -9.5% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $26.39B | +6.4% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $30.32B | +18.6% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $30.01B | +17.1% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $28.69B | +9.2% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $24.80B | -2.1% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $25.58B | +2.2% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $25.63B | +2.4% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $26.26B | +4.1% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $25.32B | -1.7% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $25.03B | -13.2% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $25.02B | -14.0% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $25.22B | -25.8% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $25.76B | -23.0% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $28.82B | -10.4% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $29.07B | -10.2% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $34.01B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $33.44B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $32.15B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $32.38B | – |
See a number that looks wrong?